ATC code A08: Difference between revisions
CSV import |
CSV import |
||
| Line 35: | Line 35: | ||
[[Category:ATC codes|A08]] | [[Category:ATC codes|A08]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 03:02, 17 March 2025
| ATC codes |
|---|
| A Alimentary tract and metabolism |
| A01 Stomatological preparations |
| A02 Drugs for acid related disorders |
| A03 Drugs for functional gastrointestinal disorders |
| A04 Antiemetics and antinauseants |
| A05 Bile and liver therapy |
| A06 Drugs for constipation |
| A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |
| A08 Antiobesity preparations, excluding diet products |
| A09 Digestives, including enzymes |
| A10 Drugs used in diabetes |
| A11 Vitamins |
| A12 Mineral supplements |
| A13 Tonics |
| A14 Anabolic agents for systemic use |
| A15 Appetite stimulants |
| A16 Other alimentary tract and metabolism products |
|
A
B
C
D
G
H
QI
J
L
M
N
P
R
S
V
|
ATC code A08 Antiobesity preparations, excluding diet products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>
ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.
</ref><ref>
ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.
</ref> Subgroup A08 is part of the anatomical group A Alimentary tract and metabolism.<ref>
ATC/DDD Index 2022
- code A08(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.
</ref>
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA08.<ref>
ATCvet Index 2022
- code QA08(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.
</ref> ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
A08A Antiobesity preparations, excluding diet products[edit]
A08AA Centrally acting antiobesity products[edit]
- A08AA01 Phentermine
- A08AA02 Fenfluramine
- A08AA03 Amfepramone
- A08AA04 Dexfenfluramine
- A08AA05 Mazindol
- A08AA06 Etilamfetamine
- A08AA07 Cathine
- A08AA08 Clobenzorex
- A08AA09 Mefenorex
- A08AA10 Sibutramine
- A08AA11 Lorcaserin
- A08AA56 Ephedrine, combinations
- A08AA62 Bupropion and naltrexone
A08AB Peripherally acting antiobesity products[edit]
- A08AB01 Orlistat
- QA08AB90 Mitratapide
- QA08AB91 Dirlotapide
A08AX Other antiobesity drugs[edit]
- A08AX01 Rimonabant
See also[edit]
- Diet products are in the ATC group V06A.
References[edit]
<references group="" responsive="1"></references>